Indication
Lipid metabolism
3 clinical trials
3 products
Product
ObicetrapibClinical trial
A Placebo-Controlled, Phase 1 Study to Investigate the Effect of Obicetrapib on Lipoprotein Metabolism.Status: Recruiting, Estimated PCD: 2024-10-30
Clinical trial
A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH Who Are Not Adequately Controlled by Their Lipid Modifying TherapiesStatus: Active (not recruiting), Estimated PCD: 2024-07-30
Product
PlaceboClinical trial
A Validation Study Evaluating the Use of 3H-Cholesterol Bound to Albumin as a Method to Assess Reverse Cholesterol Transport in Subjects With Monogenic Diseases Affecting HDL MetabolismStatus: , Estimated PCD: 2024-07-31
Product
3H-cholesterol